the repercussions of congressional inaction are clear that the fda. the agency will undertake 2100 fewer inspections which is at an 18% decline compared to last year. the implementation of the 2011 food safety modernization act will be further delayed meaning we can continue to expect an estimated cost of $75 billion annually in lost productivity and medical expenses and new drugs that reduce pain and sustain life will take longer to review and approve robbing 6 americans of improved quality of life and more time with the loved ones, by cutting services and decreasing investments critical to our economic competitiveness fees across the board budget cuts having a severe impact across all sectors of the economy. we must replace reckless, indiscriminate cuts with a renewed focus on jobs, economic growth and a balanced fiscal package that creates long-term deficit reduction. i just want to say i look forward to a day soon when chairman rogers and i can work together in a bipartisan way and really address serious issues as a result of sequestration, bring

fda tells me they will be.just think it will come more slowly. -- congressted fda wanted fda to move into a more scientific and rigorous and modern way of looking at food safety, and they are going to be forced to do it slower than they have in the past. food we are talking about safety at the fda's role in that. tomorrow, as part of our "spotlight on magazines" series, we will talk to a abouter from "harper's" going undercover at a slaughterhouse. guest: i would be curious to see what the data is on that. cdc had been using numbers that were about 10 years old looking at the numbers of foodborne illness cases. the numbers went down a bit. every year that cdc and usda produces a report that shows where foodborne illnesses are going, some numbers have gotten a pretty drastically. e. coli, which we associate with ground beef because of the jack-in-the-box outbreak in the 1990s in the northwest, e. coli actually went down a lot. the beef industry did a remarkable turnaround in terms of shifting the way that it imp

economy as is a strong fda.story shows that when the public trusts fda's oversight in the products we regulate, these industries flourish. conversely, when products cause serious high harm, it can resuln severe economic damage across the industry involved to fenders and nonoffenders alike. i want to mention some of our measurable accomplishments this past year. in 2012 fda approved 39 novel medicines, the highest number in over a decade, and the majority of these drugs were approved in the united states before anywhere else in the world. some in as little as three-and-a-half months. the number of drug shortages were cut in half compared to 2011. we successfully turned around a decade of lengthening medical device reviews and backlogs. working together with 45 state and territorial partners, we conducted more than 158,000 inspections of tobacco retailers to insure that they're not selling cigarettes or smokeless tobacco products to minors, and we published our first two food safety proposed rules as part of the i

gnc also says it does not sell substances banned or recalled by the fda.en officially band. the u.s. military prohibited selling it on bases when five months after michael sparling collapsed, a second soldier died after use can dmaa. nine countries, including canada and the uk have banned it. >> canada has banned it. the u.s. military has taken the substance out of all of its shops but you can still get it at the local store. >> it's absurd. >> the sparlings say they are waiting for the fda to demand dmaa. they are suing usp labs and gnc for causing their son's death. for the past two years, leann, with michael's dog tags around her neck, has been dropping into supplement stores to find out if they are still selling jacked. she told us about a conversation she had with a clerk a few months after michael's death. >> i said, i'm interested in a product called jacked 3-d. he goes, oh, yes. this is our top seller. >> i said, have you heard of any adverse side ekt ifs? he goes, no, it is 100% natural. it is totally safe. he goes, are you buying it for your son?

one more major development from the fda. late today it announced it is approving the plan "b" morning-after pill without a prescription for anyone 15 and older who can produce an identification. earlier this month, a federal judge ruled there should be no age restrictions and gave the fda 30 days to act. brian? >> tom costello with all things fda related from washington tonight. tom, thanks. >>> new numbers out tonight about home prices. the highest annual jump in nearly seven years. 9.3% according to one closely watched index. and that's in all 20 of the biggest cities in this country. one reason prices are rising so fast? inventory, pure and simple. there is very little out there to buy. with fewer new listings than we see, especially during this time of year. >>> still ahead for us as we continue tonight, taking down historic churches to put up a new stadium. it's a wrenching problem involving big money and progress and the wrecking ball. >>> and later, what happened today to the eternal flame at the jfk burial site. the

the fda approved, for example, for women -- there is no fda approved testosterone for women. it has been shown conclusively that women have a higher risk for heart disease and cancer if their testosterone levels are too high. approved is no fda testosterone medication for it. the only way to provide that to those women is to use a compounded medication. forfda approved medications menopausal women who have problems, the recommendation from the large organizations, the american menopause society, is to get the lowest dose possible for the shortest period of time, but their own scientific literature shows are optimal levels beneficial for the women. the fda approved medications do not reach those therapeutic levels. host: anna edney. guest: you make a good point. ares a question that people asking, particularly republicans in the house. they have not gotten behind any effort for legislation. they're asking -- that's why they held the steering -- what could he fda do with the powers they already have. doe wanto give them more? am thinking the states should be able to retain what

economy as is the most from fda. -- trustsublic trust the fda oversight, these industries flourished.here is severe economic issues involved. the measurableon accomplishments this year. 39 novel medicines, the highest number in over a decade, and the majority of these drugs were approved in the united states before anywhere else in the world, some after as little as 3.5 months. the number of drug shortages were cut in half. and we turned around a decade backlog. working with state and territorial partners we conducted 150,000 tobacco retailers to make sure that they are not selling cigarettes to minors, and we published our first to food safety proposed rules with the implementation of this historic modernization act. the fda is a smart investment. consider the products we regulate, with 20 cents of every dollar. with the fda and public forars, every american pays the services and as the fda oversees a multitude of products, our job has become increasingly demanding. first we are in the middle of dramatic changes in the way that food and drugs and biological devices are produced, woul

gerri: the fda says it's almost powerless to protect us from dangerous drugs produced from what they call compounding pharmacies. we talked about this. this may change soon. a new bipartisan senate bill gives the food and drug administration control over certain compounding pharmacies. here to weigh in, grace marie turner, thanks for coming in. its great to have you here, and just to remind people, late last year, 50 people died, 700 people were made sick by drugs that came out of one of these compounding pharmacies. it was a huge scandal, and now, today, congress coingup with legislation, it's only getting started to fix this problem. do you think congress is going far enough with the proposal on the table? >> i do because they are particularly targeting these large manufacturing facilities, but are really masker raiding the pharmacies. they are legitimate pharmacies that take a medication to fit it to a prescription from a doctor. somebody's alermingic to a ingredient or need another form, but what this facility in massachusetts had done was produce on a large scale a sterile injec

don't have the resources to do is, so the fda needs resources to add this to its list of pharmacies they look at. gerri: i'm not in favor of the federal government expanding, but you have to regulate facilities. fifty people died in depth because of this, 700 people fighting this still in some cases. another phak here to explain to the viewers hat the problems are here. 22 state boards of pharmacies do not keep any historical inspection records, so not only do they have no inspectors, they don't keep records, and you don't have to have a license, toosotiou know, the lack of oversight is astonishing, and we really paid the price. last word here, grace marie? >> they do need to be licensed by the state, but the federal government, that's what the fda does is regulate the manufacturerring of large batches of pharmaceutical. this is a job for the fda and the states to then focus op smaller pharmacies that have been within their jurisdiction. gerri: thank you for coming on, great to see you, and thank you for the help. appreciate it. >> thank you. gerri: a lot more coming up, just starti

where is the fda on this? >> the fda could have been there but they made the decision in 2011 and 2012 to stop inspecting new england compounding pharmacy, the ones who developed the injectables with the fungus inside them. the fda could have gonin, and we asked repeatedly why did they stop inspecting. who made that decision. did anybodreview this after it was all said and done. we couldn't get a straight answer. what is also interesting is while she wasaying her hands were tied, she announced in a flurry of publicity last week they expected 31 different places and went in a check them out. they had complaints from physicians and pharmacists a, ad she didn't on it. gerri: the fda not doing eir job, but it isimited by law. supposed to be stateregulate in the industry, they really dropped the ball. know you probably heard this information but i want to share it with our viewers, a report, here's what it had to say. state boards of pharmacy i generally do not know what pharmacies an conduct in trade, don't know w

nicotine without the smoke and fda wants to regulate them.sk the ceo of one e-cigarette company what that would do to his business. the man who won big at wrestle mania last night, we're talking the very, very, big still wrestling, millions of bucks, with one of its biggest stars. he will join us at 10:45 this morning. look at the price of oil today. we're struggling back to $93 per barrel. now, to me, the writing is on the wall. the economy is weak, growth is slow, the jobs not there. the obama economy, in my opinion, not working. eric bolling is here, does he agree with me? his answer may surprise you. (announcer) at scottrade, our clients trade and invest exactly how they want. with scottrade's online banking, i get one view of my bank and brokerage accounts with one login... to easily move my money when i need to. plus, when i call my local scottrade office, i can talk to someone who knows how i trade. because i don't trade like everi'm with scottrade. me. (announcer) scottrade. awarded five-stars from smartmoney magazine. @ we repla

remember, playing fda roulette can be a dangerous game. they also have early stage drugs that might have a lot of potential like a severe hypercholesterolemia drug that's in phase one. could do $2 billion in peak sales, far away, though, and a hemophilia drug in phase one could do well. however, it will be years before the fda considers these two. finally, there is sangamo biosciences. a super speculative stock. market cap of just $500 million. small for us on the show. sangamo is a super high risk, high reward play. they have a proprietary technology platform that could cure genetic diseases by physically changing your dna. if all goes well, the bulls that cover the stock at j&p, they think sangamo could do about $500 million in revenues by 2018. they have two phase-two clinical trials going, trying to develop a dna-based therapy that could make a person's immune cells impervious to hiv. in other words, i'm calling it a functional cure. who knows if these trials will pan out, if the drug will be approved? if it does, obviously it would be

why the fda is getting involved. that's coming up next. like potato chips, jelly bes >>> looking for a new way to get that jolt of caffeine energy. food companies are betting snacks like potato chips and jelly beans could be the answer. the food and drug administration is watching the marketing and wants to know more. introduced this week. the fda will look at the affects on children. >> time to eat. let's see what tony has cooking today. >> has a look at this week's best buys on the lunch menu. >> it's time for this week's best buys. we save some money. each and every week i pick out three items. there's plenty to save money on. check the quality and look at your local ads. we're going to start with strawberries. the market is flooded with strawberries. the one pound tray from $1.99. i've seen them as low as $1.49 but high as $4.99. seed less cucumbers. these are great in salads and the prices are fantastic. find these for about 99 cents each. the average price is $2.99. these are field red bell peppers. all the vitamin c but the prices a

and the fda knows this. but as they've done with many food additives, they've decided that the small amounts that remain in the final product are okay. that it's not, it's not going to cause a concern. and i talk about this a fair amount in the book, and i think that this is something that's really quite a bit up for debate. but the fda, the fda could ban this ingreed credibility, or it could put pressure on manufacturers to start usingless of it. -- using less. but what it's done is please, pretty please, just use a little bit less of it which, as far as i can tell, has pretty much been ignored by the food industry. um, and the point i'd like to make in talking about subway is that, yes, processed foods are sodas and chips and chicken mcnuggets and hot pockets -- that's one of my favorites -- and twinkies, and everything that taco bell, every new product that taco bell -- strange product that they seem to come up with every other week -- but it's also a lot more than that. it's what subway sells, it's a lot

the commissioner of the fda approved this. and the court found that it was arbitrary, capricious -- >> you have hhs and the fda at each other. now, heather, you believe the judge got it right. >> i think he got it wrong. >> i'm sorry. >> he said it was arbitrary, capricious and unreasonable. it's not unreasonable to ask there be a gatekeeper for someone under the age of 17 to get this drug. normally the gatekeeper hopefully would be a parent but here you have a drug that children are not going to tell their parent that's need this drug. it's very different from aspirin. with aspirin you might say, i have a headache. does our family have -- >> shouldn't that 15-year-old who is afraid of their parentses, or telling their parents, be able to walk in and get it? the alternative would be, don't do anything and be pregnant. >> the alternative that was in place was to go get -- go to a doctor and have a prescription for it. >> a lot of kids just keep their mouths shut. is plan b really just like popping an aspirin? which is what the

"the fda is trying to stimulate investment in antibiotic and anti-infectious space." another reason for investors to take a look at biotech: there's a lot of work being done on the treatment of alzheimer's, a disease affecting more than five million americans. the first alzheimer's prevention trial is underway. it's the first to evaluate an alzheimer's treatment before the disease ravages patients' brains. huge profits expected from ford motors: the car-maker is poised to post its highest north american first quarter profit ever. analysts estimate that ford earned $2.7 billion in the first three months this year. it's largely due to sales of the ford fusion. ford earnings are due today. hearings continue today regarding boeing's dreamliner mishap. national transportation safety board members will question officials about the aircraft's lithium ion batteries that erupted in fire just months ago. "we are looking for lessons learned: not just for design and certification of the failed battery, but for knowledge that can be applied to emerging technologies going forward.

>>> well, the fda bursts caffeinated gum's bubble. the government worried. >>> jurors weigh the fate of the philadelphia abortion doctor, accused in the deaths of several babies. of several babies. eyewitness,,,, [ dog growls, barks ] bring your dog to work day. not our best idea. [ dog barking ] george stop it. stop. ooh. it was a nice thought. [ male announcer ] some business decisions are better than others. the best decision is switching to verizon. you're good to go. that was fast. thank you. [ male announcer ] choose verizon fios and get 100% fiber optic fast internet and business class phone both with 99.9% network reliability on an unparalleled fiber network. you'll get consistently fast speeds and unlimited internet usage that's never capped. all for just $99.99 a month with a two year price guarantee. plus get an additional line included. call 1.888.410.4404 to sign up today. it's all backed by our worry free guarantee, with no activation fees, and more. or supercharge your internet with fios quantum for business. triple you

and the company plans to file for fda approval in 2014.company has a third cystic fibrosis drug in phase two development that we can get more data on sometime this quarter. and vertex also has the hepatitis c franchise, being eaten alive by the competition. but even though the other guys may have a better mousetrap, generating over $1 billion in sales last year. the company's next drug in phase two development, the street isn't expecting much from them but that could give vertex's pipeline a kicker. i'm saying there are many ways to win with vertex. next up, sarepta therapeutics. remember this one? $1.6 billion. much smaller. the company with a $36 stock that's eight points off its high. i recommended this back on september 21st when it was trading at $14.47. since then, 152% gain. remember, this is biotech. you can get these gains. this is not att or verizon, although i like those. those put you to sleep. sarepta is developing a drug for muscular dystrophy, a condition that leaves patients wheelchair bound by their teens and dead shortly

the fda made this decision based on science. a court said the administration should let the fda's decision stand. >> reporter: the ruling today says the government's refusal to allow access to the pill was arbitrary, ka preeshcapricious, unreasonable. the judge ordered the fda to lift the restrictions within 30 days, a move critics oppose. >> our concern is that this ruling negatively affect the hasty of young girls and circumvents the rights of parents to be involved in important health decisions regarding their daughters. >> reporter: part of a decade-long battle over who should have access to the plan b pill. which if taken within 72 hours of unprotected sex can reduce chances of pregnancy. it prevents ovulation or fertilization of an egg but has no effect if a woman is already pregnant. the justice department says it will act promptly in decide whether to appeal the decision. nbc news. >>> in other health news today, the cdc said it is actively monitor the new bird flu strain in china. so far there's no reason for concern he

we want to trust the fda in all decisiones. what does it mean we can't trust in decision of reproductive health. it is just important that agencies do not get involved in politics and can make these kind of healthcare decisions on the merit. >> that's an important point. there is a legal process here, which is the basis of the decision. >> i want young women to have control over their bodies because then they can control their destiny. >> yes. >> that's the core of the issue. i want you to have control over it from 11 to 87. i want you to have control. >> when they get jobs they can control -- >> that's the new standard. >> in my household -- >> the head of the fda with a drug contingency of tamper proof bottle on emergency contraception. you have to have a job to open it. >> here is the thing, it doesn't work, right. >> right. >> what helps is more information, more access, more safety, less stigma. that's what our goal should be. >> i want to talk about this camel hairs thing. i think it is important. like someone said someth

fda is looking into increasing number of seri serious medical problems and even death.ng 500 incidents, a doctor could not control movements andl was ripped. and also doctors say it's the device but they say there are other things. >> during an operation when there needs to be an emergency cpr or to an operation, the robot has gotten in the way. >> in a written statement the maker of the only fda robotic device, it has an excellent safety record, questions are surfacing and now the fda is looking for answers. >> tomorrow a south bay post office will bear the name of hometown hero. kenneth ballard was killing while serving in iraq. tomorrow a post office in mountain view will be dedicated in his honor. congresswoman authored legislation to designate the facility as his memorial post office. >> dan: this is wild. all that spare change being left behind at airport security checkpoints, it's adding up to more than half a million dollars. j.f.k. and o'hare and miami international airports have each collected $70,000 from rushing travelers who forgot to pick up their change o

however, the fda approving it isn't meaningless. it validates the whole thing.unogen's technology. and that's important because this company has a pipeline full of drugs it owns outright. they've got a small cell lung cancer treatment, we should get phase two data on that in the second half of this year. and then immunogen with some early stage drugs. one for lung. one for lymphoma, head and neck cancer, but these will all take years before they're ready to be submitted to the fda if they ever are. this stock has up since the beginning of the year. now, i got to wait for a pullback. the company has a big analyst day coming on friday of next week, april 12th. you know what, we've got a big downturn off a country you never heard of that did something to the bond market, that may be the opportunity you want to get in ahead of the catalyst of the analyst meeting. how about the seattle genetics? here's another stock that rallied hard, 50% gains since i recommended it just after interviewing the ceo last june. just like immunogen, they've got the same thing, the targe

fda is looking into increasing number of serious medical problems and even death.mong 500 incidents, a doctor could not control movements and death after a patient's bowel was ripped. and also doctors say it's the device but they say there are other things. >> during an operation when there needs to be an emergency cpr or to an operation, the robot has gotten in the way. >> in a written statement the maker of the only fda robotic device, it has an excellent safety record, questions are surfacing and now the fda is looking for answers. >> tomorrow a south bay post office will bear the name of hometown hero. kenneth ballard was killing while serving in iraq. tomorrow a post office in mountain view will be dedicated in his honor. congresswoman authored legislation to designate the facility as his memorial post office. >> dan: this is wild. all that spare change being left behind at airport security checkpoints, it's adding up to more than half a million dollars. j.f.k. and o'hare and miami international airports have each collected $70,000 from rushing travelers who f

fda is looking into increasing number of serious medical problems and even death. among 500 incidents, a doctor could not control movements and death after a patient's bowel was ripped. and also doctors say it's the device but they say there are other things. >> during an operation when there needs to be an emergency cpr or to an operation, the robot has gotten in the way. >> in a written statement the maker of the only fda robotic device, it has an excellent safety record, questions are surfacing and now the fda is looking for answers. >> tomorrow a south bay post office will bear the name of hometown hero. kenneth ballard was killing while serving in iraq. tomorrow a post office in mountain view will be dedicated in his honor. congresswoman authored legislation to designate the facility as his memorial post office. >> dan: this is wild. all that spare change being left behind at airport security checkpoints, it's adding up to more than half a million dollars. j.f.k. and o'hare and miami international airports have each collected $70,000 from rushing travelers who

the fda is already looking at energy drinks and shots.ime the fda explicitly gave permission to add caffeine was in the 1950s for sodas. >>> a prototype spacecraft that would ferry tourists into space passed a key test. virgin galactic spaceship 2 had a successful rocket fired flight after being released from the carrier aircraft over the desert. founder richard branson was thrilled. >> it couldn't have gone more smoothly. we just talked to the pilots. they were thinking of saying screw everybody we're going into space. >> virgin galactic plans to reach space by the end of the year. already more than 500 space tourists put a deposit down on the $200,000 ticket price. >> why not? it's just 200,000, right? >> i got my ticket. >> ashley morrison in new york. thank you. >>> straight ahead, your tuesday morning weather and in sports, tebow's time is up in the big apple. find out what might be next for the star quarterback. naturals acne cleanser. re's new n® acne medicine from the wintergreen leaf treats breakouts. no parabens or harsh sulfate

what we know that is that the fda is going easy with the nicotine patch. beyond the 12 weeks of regulation, hoping to reduce the risk of smoking. one thing i found out is something called lobelia tea t. blocks the receptors of dopamine and it can take away the cravings. that's important. don't use too much. it causes vomiting. two cups a day. that's one trick that i have to prevent smoking. >> one out of five americans are still smoking. we have to get people to stop. people stop in different ways. you can't predict what will help someone. 70% do it cold turkey. 30%, it's chantics. wellbutrin sm. find lozenges and some find the gums works. if you are using the patch ov the corn, take it off at night tcan cause nightmares of i am glad the fda is saying you can smoke a cigarette with the patch because that stopped a lot of people. some patients keep smoke approximating but less and less. check in with your physician on that. i agree with the fda, beyond 12 week, as david mentioned, can be very, very helpful, sometime up to six months. a today is in 2010 prov

>> a former fda commissioner says what bugs me that people think that the fda is there to protect them but it's not. as a former fda commissioner it turns out the fda is aligned with the interest of the biotechnology companies. i have traveled to 36 countries. there is a lot of captured regulatory agencies that ignore the adverse findings and push gmos. in this case, it's an explicit instruction from the white house continuing continuing to today. >> if people want to see this documentary, genetic roulette, how do they do it? >> geneticroulettemovie.com to see the 90-minute, award-winning documentary. >> jetgeneticroulettemovie.com. it's so important that you are there. thank you for the work you are doing. thanks for coming in this morning. >> thank you. >> we will talk again. >> indeed. >> we are interested in this topic. i will be back with today's quick parting shot. >> heard around the country and seen on current tv, this is "the bill press show." may be more likely to misuse lyrica. having less pain... it's a wonderful feeling. [ female announcer ] ask your doctor about lyrica to

in september, the fda approved a colorectal cancer drug. this one could be a billion dollar drug and onyx gets a 20% royalty. right now onxx is a triple threat and that doesn't even include this pipeline. at the moment, they're developing a breast cancer drug with pfizer that's in phase three trials. this could do peak sales of $5 billion. comes to $400 million. plus, at $86 and change, onyx is unlike almost all of these others, down from its high, six points off the high, should be bought at these levels. here's the bottom line, when you're looking to future the fight against cancer, both have revolutionary technologies, but their stocks have run. they need to consolidate the gains, consolidate, do nothing for a while, go down a bit before they take off for a while. i like immunogen ahead of the analyst day. okay. you know that i think onyx is the right one. let all these stocks cool off. but if you had to buy one and you want to buy one tomorrow and you've got spare cash, onyx may be one of the best new drug companies in the world. let's

fda just improved merck's new insomnia drug in november.nd they approved ridion, merck's neuromuscular blockade drug in january. within five years after launching, these drugs could generate, collectively $800 million in revenues. $800 million. beyond that, merck has a ton of catalysts in 2013. the company is waiting on fda approval decisions for multiple drugs, including a gross pollen allergy treatment, a ragweed allergy and medication. who would not want that? an ovarian cancer drug. also important clinical trial data. clinical oncology conference in june where we focus on celgene and maybe we should focus on merck. merck will present new data on their metastatic melanoma drug although that is in phase 1 development. and we will find out whether the company will move the alzheimer's drug it's developing into phase three trials which would be a big deal that moved eli lilly ten points. and next year merck will file for approval of its osteoporosis that got delayed. and this one actually is a home run hitter. potential for more than $1 bil

and the fda agreed.n december, 2011, commissioner margaret hamburg said in a statement that plan b is safe and effective and should be approved for nonprescription use for all females of child bearing potential. on the very same day in an unprecedented move, health and human services secretary kathleen sebelius, overruled her keeping the age limit at 17. and heading into campaign season president obama agreed. >> the reason kathleen made this decision was she could not be confident that a ten-year-old or 11-year-old going to a drug store should be able alongside bubble gum or batteries to buy a medication that potentially if not used properly could have an adverse effect. >> now, 16 months later, federal district court judge edward corpsman called sebelius's decision politically motivated and ordered the fda to remove the age limits to make the drug available to all americans in the next 30 days. and now, jake, i would just point out this is really not a partisan political battle right now. i reached out

but questions are surfacing, and now the fda is looking for answers. ron claiborne, abc news, new york. >>> still ahead, right here on "world news," losing it. the major league brawl in baseball? it left a $147 million player with a major league injury. and fans with major questions about america's past time. [ male announcer ] when you're at the corner of "multivitamin" and "multiple choice," come to walgreens for help finding the one that's right for you... like centrum. now, get four dollars off select centrum products with balance rewards card. at the corner of happy and healthy. for over 30 years. and it's now the most doctor recommended, the most preferred and the most studied. so when it comes to getting the most out of your multivitamin, the choice is clear. centrum. [ male announcer ] you've reached the age where you don't back down from a challenge. this is the age of knowing how to make things happen. so, why let erectile dysfunction get in your way? talk to your doctor about viagra. 20 million men already have. ask your doctor if your heart

. >>> aaron gilchrist is on the live desk right now with news just in from the fda. >> reporter: yeah going through the statement from the fda saying it approved plan b step one, emergency contraception for 15-year-old girls without a prescription. the statement saying it will be over-the-counter. we're talking about the morning after pill and you won't need a prescription for this. and it is for girls, anyone over 15 with proof of age at the point of sale. the fda saying part of the statement that women 15 years old or older are able to understand how plan b one step works and how to use it properly in saying that they are now going to make it available for anyone 15 years old or older. the latest from the live desk, back to you. >>> there are also new concerns over the growing trend of food and drinks that tout they have an extra boost of caffeine. so the fda wants to take a closer look at them and study the impact on products and children and teens. just this week, wrigley's introduced a gum that contains about half a cup of coffee. wrigley says the product is meant for adults. the

the fda has approved the over the counter sale for the morning-after pill, for ages 15 and up. up.ck down the age age limit. they will have to ver fight piers age -- verify the buyerses age. >>> children born outside of the united states are less likely to suffer from allergies. kids born outside of the countro were significantly less likely y to have asthma, hey fever and an other types of a ledger reaction. parents need not be concerned about the study. >> these kind of studies, really shouldn't be alarming to people. i think really it's a general nl effect and we need to know moreo about it, but parents in in particular shouldn't go out and change their current practices from these studies? the risk of developing certain allergies increases after livinr in the u.s. for a decade or more. >>> an expert panel isl is recommending everyone get an hiv test. according to the preventive services task force, all teens and adults should be screenedscd for the virus.r the the task force recommends thatr women in labor should be tested for hiv if they don't already ad know their status. sta

two years and under i knew but four years or under and fda actually has put on labels.t the drugs, in front children's medication. in the back don't use children younger than four-year olds. one of the reasons why we are doing this. the trachea which the windpipe, it's narrow in kids. if they have a nose blocked with mucus, they can go to sleep and have a lot of problems. you have to be careful. >> heather: long term problems, as well? >> absolutely. but david is making a great point here. kids have underdeveloped ears compared to grownups or throats and things can gel clogged. consumer health care products association is saying under four do not give the medications. long term, what if a child has an underlying tendency to have rapid heart rate, it may affect behavior and development. >> most importantly talk to your pediatrician. there is nothing to be scared. talk to your pediatrics, over-the-counter.... >> eric: that is great point on that. thank you, doctor. >> heather: thank you both for joining us. exercise, keeps your body looking good. they are going return and

along with an hiv drug the fda is likely to decide on in august.s, maybe more phase iii data on two high-risk drug, a new cancer immune therapy drug. and a heart drug, all of which could be multibillion-dollar opportunities. this pipe is loaded. yesterday, i said merck is like the yankees. remember a lot of players in the pipeline getting on base. they're like the angels, pujols, trout, they're not living up to their potential at this moment. that's it. glaxo smithkline is an enormous company. $115 billion marketing cap. so the new products are probably too small to move the needle more than a little. but altogether? whoa. over the next three years, glaxo could launch 15 new drawings worldwide. that is a huge slate of new products that could help the company achieve an 8.4% compound annual growth rate today up through 2018, and that would be a very, very big deal. we know new products can rally the stocks, and even the large pharmaceutical companies these new drugs, because glaxo smithkline, let's say it is in a race against time. [ buzzer ] with i

fda announced it is kloog into the increasing number of serious medical problems, even deaths involving robo surgery. among 500 incidents, a malfunction during a hysterectomy. the doctor couldn't control the movement. and death. some suggest that errors by the doctor using the device but others say the device itself. >> there have been rare cases during an operation when there needs to be emergency cpr or to an operation, the robot has gotten in the way. >> in a written statement the maker of fda robotic device said it has an excellent safety event. questions are surfacing and now the fda is looking for answers. >>> new this morning, today is a national day of action by opponents of remote controlled drone aircraft. answer coalition will gather in downtown san francisco to call for an end of using drones for attacks and for domestic use by police agencies. the event coincides with protests in washington, d.c., los angeles, sacramento and other major u.s. cities. anti-drone groups say the u.s. government has used drones to kill more than 4700 people worldwide. they say the government has

we're a company that has gone through and not come out the other side years ago through the fda. the name of the game is adapt. it's always a changing environment. you just have to adapt. >> wish we had more time. a lot more to discuss. but thank you so much. >> my pleasure. >> we can all understand the good opportunities here, not just the weather. >> your road trip is not called opportunity usa for nothing. the president unveiling his new budget plan. gene sperling will join us next. ♪ [ female announcer ] you're the boss of your life. in charge of long weekends and longer retirements. ♪ ask your financial professional how lincoln financial can help you take charge of your future. ♪ how lincbut i am your can help you takermarket data.ur future. i know what you're looking for. i'm not chained to your desk anymore. i'm faster and smarter now. and so much less expensive. i am your market data. and if i do say so myself, i have never looked better. superderivatives introduces dgx. data done differently. >> welcome back to street signs. i'm john harwood at the white house. president

i was on the food advisory committee of the fda in 1994 when the fda approved gmos. as a consumer advocate on that committee, we said go ahead, try it. but for heavens sake label it. consumers need a choice, consumers want a choice. if you don't label it, you're going to raise all kinds much questions about what are you trying to hide. i think they're trying to hide plenty. that's really what the problem is. >> what do you -- do you agree, they're trying to hide something? >> whether or not they're trying to hide something, i think this is really about freedom. we fight wars in the name of freedom. we send our kids to fight in the name of freedom. we export freedom around the world. yet we don't have the freedom of choice to know what's in our food. i'm looking at this as a consumer, as a father, three kids. i want to know what's in nair food. simple as that. >> it does feel to me like that most basic question, of just okay, if you're going to have gmos, fine, we'll make that choice. that's the freedom of entrepreneurship, the freedom of ideas in part. but why not th

huh-uh, that's not what the fda does. the fda can only look at the medical aspects. and that's why this judge he was scathing in this decision. he said that the obama administration has been arbitrary, capricious and unreasonable when it kept this away from younger girls. >> are there any medical risks for younger girls? there are people concerned about that. >> no more so than for older girls. it can cause headaches, nausea, other side effects like that, but that would be true of a 16-year-old, 26-year-old, 36-year-old. that's why this judge said you got to make it available to everybody over the counter. make it available to older women, make it available to younger women. it's interesting because the obama administration didn't argue with that but they said can younger girls understand the label? will they know how to use this? the judge said, look, we make drugs available to people of any age. if the 10-year-old can go in and buy an aspirin, she should be able to buy this too. >> when will this actually take effect? fairly soon? >> it's supposed to take effect ve

district judge order the fda to make the pill available to all ages. scientists have been recommending up restricted access and also the american associations but people we spoke to this morning didn't agree with the decision. >> i think 16 is too young, especially because if they know they can get ahold of it it is frustrating because i don't think they are old enough to make those decisions. >> the child is a minor and the parents should have the say-so. >> critics say the decision puts young girls at risk and worry about the pill being given to girls under coercion or without consent. officials at planned parenthood applaud the decision, pointing out the fda has proven it to be safe. while they especially courage open communication with parents they say it is imperative people have access to the emergency contraception. >> we are all for that kind of communication but we want teens to be able to have access to this because it is just another tool for them to be able to -- to be able to protect themselves against unintended pregnancy. >> the judge ru